Yingpeng Huang
Overview
Explore the profile of Yingpeng Huang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu F, Zhang K, Song Z, Zhou Q, Sun H, Tan Z, et al.
Dig Dis Sci
. 2024 Oct;
69(11):4098-4107.
PMID: 39414740
Background: Proline-rich tyrosine kinase 2 (PYK2) is involved in the occurrence, proliferation, migration, and invasion of various tumors. However, few studies have reported the role of PYK2 in colorectal cancer...
2.
Zhang L, Yang J, Huang Y, You T, Huang Q, Shen X, et al.
Heliyon
. 2024 Sep;
10(16):e36205.
PMID: 39253198
Objective: To conduct a comprehensive analysis of the landscape of gastric cancer (GC)-targeted therapy clinical trials and identify potential therapeutic targets. Methods: A systematic search and analysis of the Cochrane...
3.
Lu X, Chen X, Lin C, Yi Y, Zhao S, Zhu B, et al.
Adv Sci (Weinh)
. 2024 Mar;
11(18):e2309984.
PMID: 38430531
The induction of cuproptosis, a recently identified form of copper-dependent immunogenic cell death, is a promising approach for antitumor therapy. However, sufficient accumulation of intracellular copper ions (Cu) in tumor...
4.
Shao J, Jiang Z, Jiang H, Ye Q, Jiang Y, Zhang W, et al.
Ann Surg Oncol
. 2023 Dec;
31(3):1749-1759.
PMID: 38112885
Purpose: We aimed to establish a machine learning radiomics liver function model to explore how liver function affects the prognosis of patients with gastric cancer (GC). Methods: Patients with advanced...
5.
Zhang Y, Zheng W, Zhang L, Gu Y, Zhu L, Huang Y
Eur J Histochem
. 2023 Jun;
67(2).
PMID: 37340903
For the digestive system, there exists one common malignant tumor, known as gastric cancer. It is the third most prevalent type of tumor among different tumors worldwide. It has been...
6.
Xu J, Song J, Chen X, Huang Y, You T, Zhu C, et al.
Comput Biol Med
. 2023 Feb;
155:106598.
PMID: 36764156
Gastric cancer (GC) ranks fifth among all malignant tumors globally, especially in East Asia, and has attracted extensive attention and research. MicroRNA (miRNA) modulation during genomic instability (GI) may be...
7.
Zhang K, Ji X, Song Z, Wu F, Qu Y, Jin X, et al.
Comb Chem High Throughput Screen
. 2022 Jul;
26(3):630-638.
PMID: 35864794
Background: Gastric cancer (GC) remains a common cause of cancer death in East Asia. Current treatment strategies for GC, including medical and surgical interventions, are suboptimal. Butyrate, a short-chain fatty...
8.
Pan B, Liu X, Shi J, Chen Y, Xu Z, Shi D, et al.
Front Nutr
. 2022 Jan;
8:775216.
PMID: 34977119
Metabolic syndrome (MetS), accompanied with significant intestinal dysbiosis, causes a great public health burden to human society. Here, we carried out a meta-analysis to qualify randomized controlled trials (RCTs) and...
9.
Mao C, Ma L, Huang Y, Yang X, Huang H, Cai W, et al.
Front Oncol
. 2021 Nov;
11:750768.
PMID: 34804939
Background: Asians have the highest incidence of gastric cancer (GC), and the prognosis of Asian GC is poor. Furthermore, the therapeutics for Asian GC is limited because of genetic heterogeneity...
10.
Xu J, Wen J, Li S, Shen X, You T, Huang Y, et al.
Front Genet
. 2021 Jul;
12:690598.
PMID: 34290743
Recent findings have demonstrated the superiority and utility of microRNAs (miRNAs) as new biomarkers for cancer diagnosis, therapy, and prognosis. In this study, to explore the prognostic value of immune-related...